{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:51:49Z","timestamp":1761519109177},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1997,1,1]],"date-time":"1997-01-01T00:00:00Z","timestamp":852076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1007\/bf03347968","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T08:47:11Z","timestamp":1396601231000},"page":"24-28","source":"Crossref","is-referenced-by-count":13,"title":["Subacute thyroiditis during interferon-alpha therapy for chronic hepatitis C"],"prefix":"10.1007","volume":"20","author":[{"given":"Paolo","family":"Falaschi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Martocchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"D\u2019Urso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BF03347968_CR1","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/jama.1991.03470100067035","volume":"266","author":"S Baron","year":"1991","unstructured":"Baron S., Tyring S.K., Fleischmann Jr W.R., Coppenhaver D.H., Niesel D.W., Klimpel G.R., Stanton G.J., Hughes T.K. The interferons. JAMA 266: 1375, 1991.","journal-title":"JAMA"},{"key":"BF03347968_CR2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1002\/hep.1840180603","volume":"18","author":"G Saracco","year":"1993","unstructured":"Saracco G., Rosina F., Abate M.L., Chiandussi L., Gallo V., Cerutti E., Di Napoli A., Solinas A., Deplano A., Tocco A. Long-term follow-up of patients with chronic hepatitis C treated with different doses of interferon-2b. Hepatology 18: 1300, 1993.","journal-title":"Hepatology"},{"key":"BF03347968_CR3","doi-asserted-by":"crossref","first-page":"178","DOI":"10.7326\/0003-4819-115-3-178","volume":"115","author":"LE Ronnblom","year":"1991","unstructured":"Ronnblom L.E., Alm G.V., \u00d6berg K.E. Autoimmunity after alpha-interferon therapy for malignant carcinoid tumours. Ann. Intern. Med. 115: 178, 1991.","journal-title":"Ann. Intern. Med."},{"key":"BF03347968_CR4","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1507\/endocrj.41.565","volume":"41","author":"Y Nagayama","year":"1994","unstructured":"Nagayama Y., Otha K., Tsuruta M., Kimura H., Hamasaki K., Ashizawa K., Nakata K., Yokoyama N., Nagataki S. Exacerbation of thyroid autoimmunity by interferon alpha treatment in patient with viral hepatitis: our studies and review of the literature. Endocr. J. 41: 565, 1994.","journal-title":"Endocr. J."},{"key":"BF03347968_CR5","first-page":"922","volume":"80","author":"A Imagawa","year":"1995","unstructured":"Imagawa A., Itoh N., Hanafusa T., Oda Y., Waguri M., Miyagawa J., Kono Y., Kumajima M., Matsuzawa Y. Autoimmune endocrine disease induced by recombinant interferon alpha therapy for chronic type C hepatitis. J. Clin. Endocrinol. Metab. 80: 922, 1995.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347968_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/00000441-199309000-00009","volume":"306","author":"K Kamikubo","year":"1993","unstructured":"Kamikubo K., Takami R., Suwa T., Kawase Y., Shiroko J., Kametani M., Tokimitsu N., Sakata S. Case report: silent thyroiditis developed during alpha-interferon therapy. Am. J. Med. Sci. 306: 174, 1993.","journal-title":"Am. J. Med. Sci."},{"key":"BF03347968_CR7","first-page":"399","volume":"89","author":"U Watanabe","year":"1994","unstructured":"Watanabe U., Hashimoto E., Himamitsu T., Obata H., Hayashi N. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C. Am. J. Gastroenterol. 89: 399, 1994.","journal-title":"Am. J. Gastroenterol."},{"key":"BF03347968_CR8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/eje.0.1320587","volume":"132","author":"D Preziati","year":"1995","unstructured":"Preziati D., La Rosa L., Covini G., Marcelli R., Rescalli S., Persani L., Del Ninno E., Meroni P.L., Colombo M., Beck-Peccoz P. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. Eur. J. Endocrinol. 132: 587, 1995.","journal-title":"Eur. J. Endocrinol."},{"key":"BF03347968_CR9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1365-2265.1993.tb02423.x","volume":"39","author":"E Baudin","year":"1993","unstructured":"Baudin E., Marcellin P., Pouteau M., Colas-Linhart N., Le Floch J.P., Lemmonier C., Benhamou J.P., Bok B. Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C. Clin. Endocrinol. (Oxf.) 39: 657, 1993.","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BF03347968_CR10","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/0016-5085(92)90348-3","volume":"102","author":"M Lisker-Melman","year":"1992","unstructured":"Lisker-Melman M., Di Bisceglie A.M., Usala S.J., Weintraub B., Murray L.M., Hoofnagle J.H. Development of thyroid disease during therapy of chronic viral hepatitis with interferon alpha. Gastroenterology 102: 2155, 1992.","journal-title":"Gastroenterology"},{"key":"BF03347968_CR11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2249.1992.tb05852.x","volume":"90","author":"H Gisslinger","year":"1992","unstructured":"Gisslinger H., Gilly B., Woloszczuk W., Mayr W.R., Havelec L., Linkesch W., Weissei M. Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha. Clin. Exp. Immunol. 90: 363, 1992.","journal-title":"Clin. Exp. Immunol."},{"key":"BF03347968_CR12","first-page":"1106","volume-title":"Werner\u2019s. The thyroid. A fundamental and clinical text","author":"R Volp\u00e8","year":"1986","unstructured":"Volp\u00e8 R. Subacute thyroiditis. In: Ingbar S.H., Braverman L.E. (Eds.), Werner\u2019s. The thyroid. A fundamental and clinical text, ed. 5. J.B. Lippincott Company, Philadelphia, 1986, p. 1106.","edition":"5"},{"key":"BF03347968_CR13","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1097-0142(19880301)61:5<869::AID-CNCR2820610503>3.0.CO;2-I","volume":"61","author":"GA Pangalis","year":"1988","unstructured":"Pangalis G.A., Griva E. Recombinant alpha-2b-interferon therapy in untreated, stage A and B chronic lymphocytes leukemia. Cancer 61: 869, 1988.","journal-title":"Cancer"},{"key":"BF03347968_CR14","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-0609.1986.tb02290.x","volume":"36","author":"EA Abdi","year":"1986","unstructured":"Abdi E.A., Brien W., Venner P.M. Autoimmune thrombocytopenia related to interferon therapy. Scand. J. Haematol. 36: 515, 1986.","journal-title":"Scand. J. Haematol."},{"key":"BF03347968_CR15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2796.1990.tb00144.x","volume":"227","author":"LE Ronnblom","year":"1990","unstructured":"Ronnblom L.E., \u00d6berg K.E., Alm G.V. Possible induction of systemic lupus erythematosus by interferon treatment in a patient with malignant carcinoid tumour. Int. J. Med. 227: 207, 1990.","journal-title":"Int. J. Med."},{"key":"BF03347968_CR16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0140-6736(92)91744-S","volume":"340","author":"P Fabris","year":"1992","unstructured":"Fabris P., Betterle C., Floreani A., Greggio N.A., De Lazzari F., Naccarato R., Chiaramonte M. Development of type I diabetes mellitus during interferon alpha therapy for chronic HCV hepatitis. Lancet 340: 558, 1992.","journal-title":"Lancet"},{"key":"BF03347968_CR17","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0140-6736(86)91502-3","volume":"1","author":"JR Quesade","year":"1986","unstructured":"Quesade J.R., Gutterman J.U. Psoriasis and alpha-interferon. Lancet 1: 1466, 1986.","journal-title":"Lancet"},{"key":"BF03347968_CR18","first-page":"1","volume":"22","author":"G Fattovich","year":"1995","unstructured":"Fattovich G., Giustina G., Favarato S., Ruol A. and Investigators of the Italian Association for the Study of the Liver. A survey of adverse events in 11241 patients with chronic viral hepatitis treated with alfa interferon. J. Hepatol. 22: 1, 1995.","journal-title":"J. Hepatol."},{"key":"BF03347968_CR19","unstructured":"Shimizu H., Ohtani K., Tanaka Y., Uehara Y. Interleukin-6 may mediate activation of pituitary-adrenal axis by interferon-alpha. 75h Annual Meeting of the Endocrine Society. Las Vegas, Nevada, June 9\u201312, 1993 (Abstr. n\u00b01666)."},{"key":"BF03347968_CR20","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(83)90629-3","volume":"12","author":"GF Bottazzo","year":"1983","unstructured":"Bottazzo G.F., Pujol-Borrell R., Hanafusa T., Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 12: 1115, 1983.","journal-title":"Lancet"},{"key":"BF03347968_CR21","first-page":"101","volume-title":"Fundamentals of clinical endocrinology","author":"R Hall","year":"1989","unstructured":"Hall R. Subacute (De Quervain\u2019s) thyroiditis. In: Hall R., Besser G.M. (Eds.), Fundamentals of clinical endocrinology. Churchill Livingstone, Edinburgh, 1989, p. 101."},{"key":"BF03347968_CR22","first-page":"905","volume":"18","author":"L Wesenfelder","year":"1994","unstructured":"Wesenfelder L., Raynard B., Eug\u00e8ne C., Anciaux M.L., Quevauvilliers J. Thyro\u00efdite subaigu\u00eb de De Quervain r\u00e9v\u00e9lant une h\u00e9patite \u00e0 virus A. Gastroenterol. Clin. Biol. 18: 905, 1994.","journal-title":"Gastroenterol. Clin. Biol."},{"key":"BF03347968_CR23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1210\/jcem-45-2-270","volume":"45","author":"S Nyulassy","year":"1977","unstructured":"Nyulassy S., Hnilica P., Buc M., Guman M., Hirschova V., Stefanovic J. Subacute (De Quervain\u2019s) thyroiditis: association with HLA-Bw35 antigen and abnormalities of the complement system, immunoglobulins and other serum proteins. J. Clin. Endocrinol. Metab. 45: 270, 1977.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03347968_CR24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0167-5699(92)90083-J","volume":"13","author":"S Romagnani","year":"1992","unstructured":"Romagnani S. Induction of Th1 and Th2 response: a key role for the \u201cnatural\u201d immune response? Immunol. Today 13: 379, 1992.","journal-title":"Immunol. Today"},{"key":"BF03347968_CR25","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/0168-8278(95)80291-6","volume":"22","author":"P Marcellin","year":"1995","unstructured":"Marcellin P., Pouteau M., Benahamou J.P. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J. Hepatol. 22: 364, 1995.","journal-title":"J. Hepatol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347968.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347968\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347968","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:42:08Z","timestamp":1558507328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["BF03347968"],"URL":"https:\/\/doi.org\/10.1007\/bf03347968","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}